Prognostic value of blood-based biomarkers in multiple sclerosis patients in the absence of clinical relapses or new MRI lesions
Background: In multiple sclerosis (MS), an increase in whole-brain lesion volume (LV) on MRI can be observed even in the absence of newly demarcated focal lesions or clinical relapses. However, it is unknown whether the presence of increasing LV alone is enough to justify changes in the therapeutic...
Spremljeno u:
| Glavni autori: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publishing
2025-11-01
|
| Serija: | Therapeutic Advances in Neurological Disorders |
| Online pristup: | https://doi.org/10.1177/17562864251374903 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|